UAB “Ligence” is excited to announce the launch of our newly funded project, “Strengthening Ligence export potential” (Project code: 02-121-K-0191). This initiative is directed at expanding the export of our artificial intelligence solution, “Ligence Heart,” into new foreign markets while strengthening our presence in existing ones.
Our Primary Goal
The core objective of this project is to strengthen our company’s export potential and increase sales volumes in key foreign markets. By implementing targeted export promotion activities, we aim to convert existing sales opportunities into actual contracts and establish new, sustainable connections with potential clients.
Planned Activities
- Product Certification: We are investing in certification services to obtain FDA 510(k) additional clearances for the “Ligence Heart” product. This is a crucial step for the safe and legal placement of our product in the US market.
- International Exhibitions: We will present our company and product at international specialized exhibitions abroad to attract new clients and accelerate sales conversions.
Expected Results
Through these activities, we expect to achieve the following outcomes:
- Present our products at 6 international exhibitions.
- Successfully certify 1 product.
- Significantly increase the export value of our Lithuanian-origin products over the coming years.
This project is implemented with a total budget of €102,552.63. It is co-funded by the European Union, which is providing €51,276.31 in support.
